Data search
Results for MligTC455_19049
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_19049 | 17 | 0.34 | Mlig455_049572 | Neo: - Age: - Region-enriched R2: 8.023/0.01333 |
Mlig455_049572 {REF} {Length: 1581} {Pfam: Spt20 family [PF12090.10, score=18.3]} |
Cumulative graph for MligTC455_19049
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -8.891 | 0.611 | 0.99976 | 1.00000 | |
| RegionR2 | 8.023 | 0.611 | 0.00050 | 0.01333 | |
| RegionR3 | 1.864 | 0.611 | 0.99986 | 1.00000 | |
| RegionR4 | -2.556 | 0.611 | 0.99969 | 1.00000 | |
| RegionR5 | 3.383 | 0.611 | 0.02054 | 0.09894 | |
| RegionR6 | 1.433 | 0.611 | 0.99987 | 1.00000 | |
| RegionR7 | 0.146 | 0.611 | 0.99982 | 1.00000 | |
| RegionR8 | -3.402 | 0.611 | 0.99961 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 4.039 | 0.611 | 0.99990 | 1.00000 | |
| RegenerationR2 | -1.991 | 0.611 | 0.02490 | 0.26073 | |
| RegenerationR3 | 0.328 | 0.611 | 0.99996 | 1.00000 | |
| RegenerationR4 | 1.433 | 0.611 | 0.99980 | 1.00000 | |
| RegenerationR5 | -1.89 | 0.611 | 0.26982 | 0.70151 | |
| RegenerationR6 | 0.273 | 0.611 | 1.00000 | 1.00000 | |
| RegenerationBL | 1.227 | 0.611 | 0.99993 | 1.00000 | |
| RegenerationTP | 1.482 | 0.611 | 0.99984 | 1.00000 |
Genes with expression patterns similar to MligTC455_19049
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_19049 | 17 | 0.34 | Mlig455_049572 | Neo: - Age: - Region-enriched R2: 8.023/0.01333 |
2 | - | - | 1.000 | - | 1.000 | - | Mlig455_049572 {REF} {Length: 1581} {Pfam: Spt20 family [PF12090.10, score=18.3]} | |
| 2. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1.97 | - | - | 0.974 | - | 0.996 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
| 3. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 1.952 | - | - | 0.971 | - | 0.981 | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
| 4. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 1.949 | - | - | 0.955 | - | 0.994 | - | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
| 5. | MligTC455_37058 | 19 | 0.4 | Mlig455_061075 | Neo: - Age: - |
1.946 | - | - | 0.960 | - | 0.986 | - | Mlig455_061075 {REF} {Length: 4598} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=31.8]} {RNA1509_56135} {RNA1310_6435} {RNA815_17633} | |
| 6. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 1.946 | - | - | 0.967 | - | 0.979 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
| 7. | MligTC455_53461 | 15 | 0.31 | Mlig455_007127 | Neo: - Age: - |
PLCE1 | 1.946 | - | - | 0.966 | - | 0.980 | - | Mlig455_007127 {REF} {Length: 9858} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=203.6]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=104.3]; FERM central domain [PF00373.20, score=30.1]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]; C2 domain [PF00168.32, score=24.5]; RasGEF domain [PF00617.21, score=24.5]; Ras association (RalGDS/AF-6) domain [PF00788.25, score=20.8]} {Human: ENSG00000138193, PLCE1, phospholipase C epsilon 1, [Score=530, Expect=8e-152]} {Mouse: ENSMUSG00000024998, Plce1, phospholipase C, epsilon 1, [Score=524, Expect=4e-150]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=161, Expect=4e-39]} {Celegans: WBGene00004036, plc-1, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, [Score=436, Expect=1e-123]} {Smed: dd_Smed_v6_9716_1_1, dd_Smed_v6_9716_1_1, [Score=507, Expect=8e-145]} {RNA1310_38856} {RNA815_52816} |
| 8. | MligTC455_23006 | 48 | 1 | Mlig455_001776 | Neo: - Age: logFC(26M/2M)=-0.676 |
1.938 | - | - | 0.974 | - | 0.964 | - | Mlig455_001776 {REF} {Length: 2604} {RNA1310_41105} {RNA815_50956} | |
| 9. | MligTC455_51881 | 14 | 0.3 | Mlig455_047149, Mlig455_047294 | Neo: - Age: - |
CHAC1 | 1.93 | - | - | 0.930 | - | 1.000 | - | Mlig455_047149 {REF} {Length: 1045} {Pfam: ChaC-like protein [PF04752.14, score=137.0]} {Human: ENSG00000128965, CHAC1, ChaC glutathione specific gamma-glutamylcyclotransferase 1, [Score=134, Expect=5e-39]} {Mouse: ENSMUSG00000027313, Chac1, ChaC, cation transport regulator 1, [Score=133, Expect=1e-38]} {Dmel: FBgn0039109, CG10365, [Score=112, Expect=5e-30]} {Celegans: WBGene00017724, F22F7.7, Gamma-glutamylcyclotransferase, [Score=108, Expect=9e-30]} {Smed: dd_Smed_v6_2439_0_1, dd_Smed_v6_2439_0_1, [Score=155, Expect=1e-47]} {RNA1310_83351} Mlig455_047294 {REF} {Length: 1073} {Pfam: ChaC-like protein [PF04752.14, score=166.0]} {Human: ENSG00000128965, CHAC1, ChaC glutathione specific gamma-glutamylcyclotransferase 1, [RH, Score=153, Expect=6e-46]} {Mouse: ENSMUSG00000027313, Chac1, ChaC, cation transport regulator 1, [RH, Score=150, Expect=6e-45]} {Dmel: FBgn0039109, CG10365, [Score=131, Expect=5e-37]} {Celegans: WBGene00017724, F22F7.7, Gamma-glutamylcyclotransferase, [RH, Score=126, Expect=9e-36]} {Smed: dd_Smed_v6_2439_0_1, dd_Smed_v6_2439_0_1, [Score=182, Expect=2e-57]} {RNA1310_83351} |
| 10. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
1.928 | - | - | 0.957 | - | 0.971 | - | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
| 11. | MligTC455_35813 | 35 | 0.73 | Mlig455_013562, Mlig455_013615 | Neo: - Age: - Region-enriched R2: 7.733/0.00085 |
NPR2 | 1.927 | - | - | 0.937 | - | 0.990 | - | Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869} Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407} |
| 12. | MligTC455_19547 | 11 | 0.23 | Mlig455_068540 | Neo: - Age: - |
CUBN | 1.924 | - | - | 1.000 | - | 0.924 | - | Mlig455_068540 {REF} {Length: 3105} {Pfam: CUB domain [PF00431.22, score=94.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=63.9, Expect=1e-09]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=64.3, Expect=5e-10]} {Dmel: FBgn0261262, CG42613, [Score=95.9, Expect=5e-20]} {Celegans: WBGene00010587, sol-2, SOL-2 protein; Suppressor Of Lurcher movement defect, [Score=105, Expect=6e-24]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=72.8, Expect=3e-13]} {RNA1310_54691} |
| 13. | MligTC455_21227 | 18 | 0.37 | Mlig455_018373 | Neo: - Age: - |
RGS6 | 1.919 | - | - | 0.921 | - | 0.998 | - | Mlig455_018373 {REF} {Length: 2679} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=113.6]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.8]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=315, Expect=1e-99]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=310, Expect=5e-98]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=310, Expect=1e-97]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=305, Expect=4e-96]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=5e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=242, Expect=3e-72]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=392, Expect=8e-130]} {RNA1310_24067} |
| 14. | MligTC455_41724 | 23 | 0.49 | Mlig455_001647 | Neo: - |
1.916 | - | - | 0.940 | - | 0.976 | - | Mlig455_001647 {REF} {Length: 1808} {RNA1310_22665} {RNA815_13308} | |
| 15. | MligTC455_33939 | 15 | 0.31 | Mlig455_018477 | Neo: Int S/G2/M |
GUCY1B1 | 1.914 | - | - | 0.940 | - | 0.974 | - | Mlig455_018477 {REF} {Length: 4178} {Pfam: Heme NO binding associated [PF07701.16, score=239.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=198.0]; Haem-NO-binding [PF07700.17, score=172.7]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=343, Expect=9e-106]} {Mouse: ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=350, Expect=4e-106]; ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=348, Expect=7e-108]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=622, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=530, Expect=2e-176]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=818, Expect=0.0]} {RNA1509_41885} {RNA1310_21359} {RNA815_6599.2} |
| 16. | MligTC455_22402 | 31 | 0.64 | Mlig455_012784 | Neo: - Age: - |
1.908 | - | - | 0.913 | - | 0.995 | - | Mlig455_012784 {REF} {Length: 1963} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_96760.2} {RNA815_54296} | |
| 17. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
1.906 | - | - | 0.933 | - | 0.973 | - | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
| 18. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
1.905 | - | - | 0.910 | - | 0.995 | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
| 19. | MligTC455_12152 | 19 | 0.39 | Mlig455_066811 | Neo: - Age: - |
GPRIN2 | 1.904 | - | - | 0.928 | - | 0.976 | - | Mlig455_066811 {REF} {Length: 1594} {Pfam: G protein-regulated inducer of neurite outgrowth C-terminus [PF15235.8, score=49.2]} {Human: ENSG00000204175, GPRIN2, G protein regulated inducer of neurite outgrowth 2, [RH, Score=55.8, Expect=1e-07]} {Mouse: ENSMUSG00000071531, Gprin2, G protein regulated inducer of neurite outgrowth 2, [RH, Score=53.9, Expect=2e-07]; ENSMUSG00000069227, Gprin1, G protein-regulated inducer of neurite outgrowth 1, [RH, Score=53.9, Expect=3e-07]; ENSMUSG00000045441, Gprin3, GPRIN family member 3, [RH, Score=52.0, Expect=1e-06]} {Smed: dd_Smed_v6_10294_0_1, dd_Smed_v6_10294_0_1, [RH, Score=87.8, Expect=2e-18]} {RNA1310_92598} {RNA815_63284} |
| 20. | MligTC455_09442 | 12 | 0.24 | Mlig455_065765 | Neo: - Age: - |
GABBR2 | 1.903 | - | - | 0.903 | - | 1.000 | - | Mlig455_065765 {REF} {Length: 2959} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=146.7]; Receptor family ligand binding region [PF01094.30, score=114.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=285, Expect=7e-82]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=280, Expect=4e-80]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=239, Expect=2e-65]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=222, Expect=1e-60]} {Smed: dd_Smed_v6_20665_0_1, dd_Smed_v6_20665_0_1, [Score=140, Expect=6e-34]} {RNA1509_58025} {RNA1310_57812} {RNA815_11540} |
| 21. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.902 | - | - | 0.905 | - | 0.997 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
| 22. | MligTC455_12126 | 26 | 0.55 | Mlig455_040946 | Neo: - Age: - |
1.893 | - | - | 0.905 | - | 0.988 | - | Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956} | |
| 23. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
1.881 | - | - | 0.888 | - | 0.993 | - | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
| 24. | MligTC455_07705 | 6 | 0.13 | Mlig455_012841 | Neo: - Age: - |
1.879 | - | - | 0.879 | - | 1.000 | - | Mlig455_012841 {REF} {Length: 1042} {Smed: dd_Smed_v6_38985_0_1, dd_Smed_v6_38985_0_1, [Score=54.3, Expect=9e-09]} {RNA1310_136328} | |
| 25. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
1.879 | - | - | 0.907 | - | 0.972 | - | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
| 26. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 1.878 | - | - | 0.878 | - | 1.000 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
| 27. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
1.878 | - | - | 0.884 | - | 0.994 | - | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
| 28. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 1.878 | - | - | 0.879 | - | 0.999 | - | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
| 29. | MligTC455_19917 | 83 | 1.72 | Mlig455_057932, Mlig455_057967 | Neo: - Age: - |
1.877 | - | - | 0.883 | - | 0.994 | - | Mlig455_057932 {REF} {Length: 2189} {RNA1310_65401} {RNA815_48417} Mlig455_057967 {REF} {Length: 1876} {RNA1310_65401} {RNA815_48417} |
|
| 30. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
1.877 | - | - | 0.908 | - | 0.969 | - | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
| 31. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.874 | - | - | 0.882 | - | 0.992 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 32. | MligTC455_49492 | 10 | 0.21 | Mlig455_054890 | Neo: - Age: - |
1.87 | - | - | 0.870 | - | 1.000 | - | Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
| 33. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
1.87 | - | - | 0.877 | - | 0.993 | - | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
| 34. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 1.869 | - | - | 0.869 | - | 1.000 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
| 35. | MligTC455_18100 | 17 | 0.36 | Mlig455_069127 | Neo: - Age: - |
PPA1 | 1.868 | - | - | 0.882 | - | 0.986 | - | Mlig455_069127 {REF} {Length: 2015} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1509_39915} {RNA1310_57333.1} {RNA815_22340} |
| 36. | MligTC455_28719 | 17 | 0.36 | Mlig455_029838 | Neo: - Age: - |
1.868 | - | - | 0.868 | - | 1.000 | - | Mlig455_029838 {REF} {Length: 2181} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=140.7]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=90.1, Expect=4e-19]} {RNA1310_71846} {RNA815_38264} | |
| 37. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
1.864 | - | - | 0.872 | - | 0.992 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
| 38. | MligTC455_36193 | 13 | 0.27 | Mlig455_025794 | Neo: - Age: - |
B3GNT4 | 1.863 | - | - | 0.868 | - | 0.995 | - | Mlig455_025794 {REF} {Length: 3112} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=1e-20]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.2, Expect=3e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=89.7, Expect=1e-18]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
| 39. | MligTC455_40227 | 12 | 0.26 | Mlig455_010749 | Neo: - Age: - |
GRIK2 | 1.863 | - | - | 0.879 | - | 0.984 | - | Mlig455_010749 {REF} {Length: 2895} {Pfam: Ligand-gated ion channel [PF00060.28, score=133.1]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=95.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=57.0]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=306, Expect=6e-90]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=305, Expect=4e-89]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=303, Expect=1e-88]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=306, Expect=3e-90]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=303, Expect=2e-89]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=302, Expect=3e-88]} {Dmel: FBgn0039927, CG11155, [Score=291, Expect=2e-84]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=262, Expect=8e-75]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=336, Expect=1e-100]} {RNA1310_47182} {RNA815_48326} |
| 40. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
1.862 | - | - | 0.876 | - | 0.986 | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} | |
| 41. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
1.862 | - | - | 0.864 | - | 0.998 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
| 42. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
1.861 | - | - | 0.874 | - | 0.987 | - | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
| 43. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 1.861 | - | - | 0.866 | - | 0.995 | - | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
| 44. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
1.86 | - | - | 0.866 | - | 0.994 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
| 45. | MligTC455_17633 | 25 | 0.51 | Mlig455_066373 | Neo: - Age: - |
RHBG | 1.859 | - | - | 0.859 | - | 1.000 | - | Mlig455_066373 {REF} {Length: 1855} {Pfam: Ammonium Transporter Family [PF00909.23, score=389.0]} {Human: ENSG00000132677, RHBG, Rh family B glycoprotein (gene/pseudogene), [Score=60.8, Expect=3e-09]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [RH, Score=459, Expect=5e-157]} {Celegans: WBGene00000135, amt-3, Putative ammonium transporter 3, [RH, Score=401, Expect=1e-132]} {RNA1310_75971} {RNA815_45087} |
| 46. | MligTC455_19546 | 18 | 0.37 | Mlig455_053800 | Neo: - Age: - |
CUBN | 1.858 | - | - | 0.868 | - | 0.990 | - | Mlig455_053800 {REF} {Length: 3139} {Pfam: CUB domain [PF00431.22, score=96.2]} {Human: ENSG00000107611, CUBN, cubilin, [Score=65.5, Expect=3e-10]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=65.1, Expect=3e-10]} {Dmel: FBgn0261262, CG42613, [Score=93.2, Expect=2e-19]} {Celegans: WBGene00010587, sol-2, SOL-2 protein; Suppressor Of Lurcher movement defect, [Score=106, Expect=3e-24]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=73.6, Expect=2e-13]} {RNA1310_54691} |
| 47. | MligTC455_13434 | 15 | 0.3 | Mlig455_025922 | Neo: - Age: - |
1.857 | - | - | 0.879 | - | 0.978 | - | Mlig455_025922 {REF} {Length: 1467} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=36.3]} {RNA1310_51631} {RNA815_34338} | |
| 48. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
1.857 | - | - | 0.866 | - | 0.991 | - | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
| 49. | MligTC455_16846 | 158 | 3.3 | Mlig455_051873 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.265/0.00110 |
PRSS33 | 1.852 | - | - | 0.901 | - | 0.951 | - | Mlig455_051873 {REF} {Length: 1386} {Pfam: Trypsin [PF00089.28, score=189.9]; Domain of unknown function (DUF1986) [PF09342.13, score=27.5]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=154, Expect=4e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=125, Expect=2e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=3e-53]} {RNA1509_26566} {RNA1310_23561} {RNA815_9840} |
| 50. | MligTC455_16358 | 1175 | 24.47 | Mlig455_039878 | Neo: - Age: - Region-specific R2: 4.659 Region-enriched R2: 4.310/0.00000 |
1.851 | - | - | 0.875 | - | 0.976 | - | Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1} | |
| 51. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
1.85 | - | - | 0.889 | - | 0.961 | - | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
| 52. | MligTC455_40388 | 23 | 0.47 | Mlig455_019615 | Neo: - Age: - |
1.849 | - | - | 0.849 | - | 1.000 | - | Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562} | |
| 53. | MligTC455_49077 | 11 | 0.22 | Mlig455_028465 | Neo: - Age: - |
SCNN1B | 1.849 | - | - | 0.868 | - | 0.981 | - | Mlig455_028465 {REF} {Length: 1973} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=191.1]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=75.9, Expect=9e-14]} {Mouse: ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=65.9, Expect=6e-11]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=62.8, Expect=7e-10]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=70.1, Expect=2e-12]} {Smed: dd_Smed_v6_26855_0_1, dd_Smed_v6_26855_0_1, [Score=260, Expect=5e-79]} {RNA1310_116633} |
| 54. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
1.848 | - | - | 0.879 | - | 0.969 | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
| 55. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.848 | - | - | 0.877 | - | 0.971 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
| 56. | MligTC455_13433 | 11 | 0.22 | Mlig455_025860 | Neo: - Age: - Region-enriched R2: 6.296/0.01497 |
1.847 | - | - | 0.879 | - | 0.968 | - | Mlig455_025860 {REF} {Length: 1640} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=35.7]} {RNA1310_51631} {RNA815_34338} | |
| 57. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 1.847 | - | - | 0.867 | - | 0.980 | - | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
| 58. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.847 | - | - | 0.863 | - | 0.984 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
| 59. | MligTC455_13072 | 18 | 0.37 | Mlig455_066620 | Neo: - Age: - |
HDC | 1.846 | - | - | 0.856 | - | 0.990 | - | Mlig455_066620 {REF} {Length: 3571} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=359.4]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=26.2]} {Human: ENSG00000140287, HDC, histidine decarboxylase, [RH, Score=493, Expect=1e-167]} {Mouse: ENSMUSG00000027360, Hdc, histidine decarboxylase, [Score=466, Expect=9e-157]} {Dmel: FBgn0005619, Hdc, Histidine decarboxylase, [Score=516, Expect=5e-177]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=404, Expect=8e-133]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=409, Expect=9e-137]} {RNA1310_91546} |
| 60. | MligTC455_15771 | 15 | 0.31 | Mlig455_013616 | Neo: - Age: - |
1.846 | - | - | 0.872 | - | 0.974 | - | Mlig455_013616 {REF} {Length: 1678} {Pfam: Glycine rich protein [PF12810.9, score=28.8]} {RNA1509_48637} {RNA1310_55197} {RNA815_27869} | |
| 61. | MligTC455_19526 | 40 | 0.84 | Mlig455_032263 | Neo: - Age: - Region-enriched R5: 4.476/0.00075 |
1.845 | - | - | 0.877 | - | 0.968 | - | Mlig455_032263 {REF} {Length: 986} {RNA1509_59284} {RNA1310_56370} {RNA815_27780} | |
| 62. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 1.845 | - | - | 0.854 | - | 0.991 | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
| 63. | MligTC455_10017 | 8 | 0.17 | Mlig455_034677 | Neo: - Age: - |
GUCY2F | 1.844 | - | - | 0.844 | - | 1.000 | - | Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185} |
| 64. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.844 | - | - | 0.858 | - | 0.986 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
| 65. | MligTC455_16847 | 1240 | 25.83 | Mlig455_051898, Mlig455_053146 | Neo: - Age: Down-Up-Down Region-specific R2: 5.478 Region-enriched R2: 5.690/0.00000 |
PRSS33 | 1.842 | - | - | 0.867 | - | 0.975 | - | Mlig455_051898 {REF} {Length: 1360} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_29335} {RNA1310_23561} {RNA815_9840} Mlig455_053146 {REF} {Length: 1448} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_26566, RNA1509_29335} {RNA1310_23561, RNA1509_26566, RNA1509_29335} {RNA1509_26566, RNA1509_29335, RNA815_9840} |
| 66. | MligTC455_44954 | 1303 | 27.14 | Mlig455_029595, Mlig455_070648 | Neo: Int S/G2/M Age: Down-Up-Up, logFC(26M/2M)=1.023 Region-specific R2: 8.846 Region-enriched R2: 10.764/0.00000 |
1.842 | - | - | 0.847 | - | 0.995 | - | Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767} Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767} |
|
| 67. | MligTC455_16646 | 14 | 0.29 | Mlig455_038608 | Neo: - Age: - |
HTR1A | 1.841 | - | - | 0.845 | - | 0.996 | - | Mlig455_038608 {REF} {Length: 1523} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=49.9]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=71.6, Expect=7e-16]} {Mouse: ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [Score=68.2, Expect=7e-15]; ENSMUSG00000022705, Drd3, dopamine receptor D3, [Score=65.1, Expect=9e-14]} {Dmel: FBgn0038063, Octbeta2R, Octopamine beta2 receptor, [Score=72.0, Expect=3e-16]} {Celegans: WBGene00016872, dop-4, Dopamine receptor 4, [Score=60.8, Expect=1e-12]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=118, Expect=3e-33]} {RNA1509_58224} {RNA1310_114359} {RNA815_11051.1} |
| 68. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.841 | - | - | 0.847 | - | 0.994 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 69. | MligTC455_20643 | 34 | 0.72 | Mlig455_066722 | Neo: - Age: - |
CHRNA6 | 1.839 | - | - | 0.848 | - | 0.991 | - | Mlig455_066722 {REF} {Length: 3504} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=224.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.3]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=357, Expect=6e-118]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=355, Expect=6e-117]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=352, Expect=1e-115]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=340, Expect=1e-111]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=340, Expect=1e-111]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=358, Expect=2e-118]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=355, Expect=3e-117]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=345, Expect=4e-113]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=341, Expect=1e-111]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=435, Expect=1e-148]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=371, Expect=8e-124]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=570, Expect=0.0]} {RNA1509_52151} {RNA1310_16118} {RNA815_53101} |
| 70. | MligTC455_51386 | 763 | 15.89 | Mlig455_041336, Mlig455_056222 | Neo: - Age: - Region-enriched R2: 3.643/0.00016 |
HPGDS | 1.836 | - | - | 0.850 | - | 0.986 | - | Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} |
| 71. | MligTC455_53435 | 190 | 3.96 | Mlig455_045425, Mlig455_065748 | Neo: - Age: - Region-enriched R2: 4.111/0.00023 |
SYT9 | 1.836 | - | - | 0.878 | - | 0.958 | - | Mlig455_045425 {REF} {Length: 2615} {RNA1509_46689} {RNA1310_15031, RNA1509_46689} {RNA1509_46689, RNA815_18779.1} Mlig455_065748 {REF} {Length: 3143} {Pfam: C2 domain [PF00168.32, score=116.1]} {Human: ENSG00000170743, SYT9, synaptotagmin 9, [Score=162, Expect=4e-42]; ENSG00000213023, SYT3, synaptotagmin 3, [Score=157, Expect=5e-40]} {Mouse: ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=162, Expect=3e-42]; ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=156, Expect=1e-39]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [RH, Score=197, Expect=1e-54]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=144, Expect=8e-37]} {Smed: dd_Smed_v6_6730_0_1, dd_Smed_v6_6730_0_1, [Score=155, Expect=5e-41]} {RNA1509_46689} {RNA1310_15031} {RNA815_18779.1} |
| 72. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
1.835 | - | - | 0.864 | - | 0.971 | - | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
| 73. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 1.831 | - | - | 0.880 | - | 0.951 | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
| 74. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.83 | - | - | 0.853 | - | 0.977 | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
| 75. | MligTC455_12867 | 14 | 0.29 | Mlig455_049571 | Neo: - Age: - |
KCNIP3 | 1.827 | - | - | 0.832 | - | 0.995 | - | Mlig455_049571 {REF} {Length: 1857} {Pfam: EF-hand domain pair [PF13499.8, score=50.8]; EF hand [PF00036.34, score=44.5]; EF-hand domain [PF13405.8, score=39.6]; EF-hand domain pair [PF13833.8, score=32.7]; EF hand [PF13202.8, score=30.8]} {Human: ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=155, Expect=4e-44]; ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=148, Expect=1e-41]} {Mouse: ENSMUSG00000025221, Kcnip2, Kv channel-interacting protein 2, [Score=146, Expect=4e-41]; ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=140, Expect=7e-39]} {Dmel: FBgn0265595, CG44422, [Score=154, Expect=3e-42]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=125, Expect=1e-33]} {Smed: dd_Smed_v6_9434_0_1, dd_Smed_v6_9434_0_1, [Score=127, Expect=2e-34]} {RNA1310_70106} {RNA815_36691} |
| 76. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 1.827 | - | - | 0.853 | - | 0.974 | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
| 77. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 1.826 | - | - | 0.871 | - | 0.955 | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
| 78. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.826 | - | - | 0.830 | - | 0.996 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
| 79. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 1.825 | - | - | 0.841 | - | 0.984 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
| 80. | MligTC455_47675 | 2101 | 43.77 | Mlig455_061675, Mlig455_063136 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.812 Region-specific R2: 4.381 Region-enriched R2: 4.099/0.00000 |
CLEC18C | 1.824 | - | - | 0.841 | - | 0.983 | - | Mlig455_061675 {REF} {Length: 2392} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.3]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=75.5, Expect=1e-13]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=77.8, Expect=1e-15]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=75.9, Expect=7e-15]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [Score=134, Expect=5e-33]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} Mlig455_063136 {REF} {Length: 2649} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.7]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=77.8, Expect=1e-14]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=77.4, Expect=1e-14]; ENSG00000157322, CLEC18A, C-type lectin domain family 18 member A, [RH, Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=78.2, Expect=5e-16]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00003055, lon-1, LONg, [Score=63.5, Expect=6e-11]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=136, Expect=3e-34]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} |
| 81. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
1.823 | - | - | 0.862 | - | 0.961 | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
| 82. | MligTC455_53838 | 10 | 0.21 | Mlig455_008156 | Neo: - Age: - |
1.822 | - | - | 0.822 | - | 1.000 | - | Mlig455_008156 {REF} {Length: 2378} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=7e-08]} {RNA1310_37888} {RNA815_29107} | |
| 83. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
1.819 | - | - | 0.819 | - | 1.000 | - | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
| 84. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
1.819 | - | - | 0.851 | - | 0.968 | - | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
| 85. | MligTC455_29586 | 237 | 4.95 | Mlig455_024687, Mlig455_024712 | Neo: - Age: - Region-specific R2: 5.384 Region-enriched R2: 6.584/0.00000 |
1.818 | - | - | 0.863 | - | 0.955 | - | Mlig455_024687 {REF} {Length: 1636} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} Mlig455_024712 {REF} {Length: 1612} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} |
|
| 86. | MligTC455_48692 | 15 | 0.32 | Mlig455_021398 | Neo: - Age: - Region-enriched R2: 8.096/0.02429 |
1.818 | - | - | 0.822 | - | 0.996 | - | Mlig455_021398 {REF} {Length: 1571} {Pfam: Ankyrin repeat [PF00023.32, score=20.9]; Ankyrin repeats (many copies) [PF13637.8, score=20.4]; Ankyrin repeats (many copies) [PF13857.8, score=19.6]; Ankyrin repeats (3 copies) [PF12796.9, score=19.4]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=54.7, Expect=3e-08]} {RNA1310_69005} | |
| 87. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
1.818 | - | - | 0.846 | - | 0.972 | - | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
| 88. | MligTC455_43602 | 1418 | 29.54 | Mlig455_053986 | Neo: - Age: - Region-specific R2: 4.626 Region-enriched R2: 3.844/0.00000 Regeneration-downregulated R2: -2.432 Regeneration-depleted R2: -2.432 |
1.817 | - | - | 0.856 | - | 0.961 | - | Mlig455_053986 {REF} {Length: 2161} {RNA1509_15576} {RNA1310_12096.1} {RNA815_32931} | |
| 89. | MligTC455_46982 | 256 | 5.34 | Mlig455_044826 | Neo: - Age: - |
SYN3 | 1.816 | - | - | 0.833 | - | 0.983 | - | Mlig455_044826 {REF} {Length: 2562} {TRANSSPLICED} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=168.9]} {Human: ENSG00000185666, SYN3, synapsin III, [RH, Score=176, Expect=7e-53]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=173, Expect=2e-49]; ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=6e-48]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=186, Expect=1e-54]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=105, Expect=6e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=216, Expect=3e-68]} {RNA1310_32498} {RNA815_34432} |
| 90. | MligTC455_36698 | 41 | 0.85 | Mlig455_020379, Mlig455_020438 | Neo: - Age: - Region-enriched R4: 4.050/0.03458 |
1.815 | - | - | 0.848 | - | 0.967 | - | Mlig455_020379 {REF} {Length: 1748} {Celegans: WBGene00007723, C25F9.2, [Score=77.8, Expect=7e-17]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} Mlig455_020438 {REF} {Length: 2872} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=53.1]} {Celegans: WBGene00007723, C25F9.2, [Score=206, Expect=7e-57]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} |
|
| 91. | MligTC455_44354 | 1240 | 25.82 | Mlig455_001577 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.349 Region-specific R2: 5.143 Region-enriched R2: 4.498/0.00000 Regeneration-downregulated R2: -2.807 Regeneration-depleted R2: -2.807 |
1.814 | - | - | 0.826 | - | 0.988 | - | Mlig455_001577 {REF} {Length: 1028} {RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1310_49541.2, RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1509_23470, RNA1509_33941, RNA1509_57202, RNA815_59782} | |
| 92. | MligTC455_23314 | 139 | 2.9 | Mlig455_039680 | Neo: - Age: - |
CACNA2D2 | 1.811 | - | - | 0.830 | - | 0.981 | - | Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071} |
| 93. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 1.811 | - | - | 0.815 | - | 0.996 | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
| 94. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 1.81 | - | - | 0.821 | - | 0.989 | - | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
| 95. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 1.808 | - | - | 0.814 | - | 0.994 | - | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
| 96. | MligTC455_51759 | 40 | 0.83 | Mlig455_026782 | Neo: - Age: - Region-enriched R4: 4.435/0.02831 |
CNBD2 | 1.806 | - | - | 0.833 | - | 0.973 | - | Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620} |
| 97. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 1.805 | - | - | 0.839 | - | 0.966 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
| 98. | MligTC455_05183 | 13 | 0.27 | Mlig455_003637 | Neo: - Age: - |
1.803 | - | - | 0.803 | - | 1.000 | - | Mlig455_003637 {REF} {Length: 906} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [Score=57.0, Expect=8e-10]} {RNA1310_45613} {RNA815_17816.1} | |
| 99. | MligTC455_45624 | 141 | 2.93 | Mlig455_033884, Mlig455_033892, Mlig455_033911 | Neo: Int S/G2/M Age: - |
GLRA1, GLRA3 | 1.803 | - | - | 0.839 | - | 0.964 | - | Mlig455_033884 {REF} {Length: 3237} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=129.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=62.8]} {Human: ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=242, Expect=6e-75]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=240, Expect=3e-74]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=233, Expect=3e-71]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=241, Expect=9e-75]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=235, Expect=6e-72]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=233, Expect=2e-71]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=232, Expect=5e-71]} {Dmel: FBgn0024963, GluClalpha, [Score=220, Expect=1e-66]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [Score=215, Expect=3e-65]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=260, Expect=3e-82]} {RNA1509_59352} {RNA1310_20063, RNA1509_59352} {RNA1509_59352, RNA815_17313} Mlig455_033892 {REF} {Length: 3559} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=129.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=63.1]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=240, Expect=4e-74]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=240, Expect=4e-74]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=233, Expect=2e-71]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=239, Expect=8e-74]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=235, Expect=7e-72]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=233, Expect=2e-71]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=232, Expect=4e-71]} {Dmel: FBgn0024963, GluClalpha, [Score=220, Expect=1e-66]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [Score=215, Expect=3e-65]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=260, Expect=2e-82]} {RNA1509_59352} {RNA1310_20063} {RNA815_17313} Mlig455_033911 {REF} {Length: 2594} {NoTransDecoderORF} {RNA1509_59352} {RNA1310_43340} {RNA815_27918} |
| 100. | MligTC455_46699 | 33 | 0.69 | Mlig455_037050 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.785 Region-enriched R4: 3.253/0.03515 |
1.801 | - | - | 0.806 | - | 0.995 | - | Mlig455_037050 {REF} {Length: 1266} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=36.8]; NOPS (NUC059) domain [PF08075.13, score=32.2]; YtkA-like [PF13115.8, score=19.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028} |
There are 744 more genes with r >= 0.95